SS-31 Research Guide (Preclinical Overview)
This SS-31 research guide provides principal investigators and laboratory specialists with a detailed analysis of the Szeto-Schiller-31 (Elamipretide) tetrapeptide. Synthesized for rigorous in vitro and preclinical research, SS-31 represents a unique class of mitochondria-targeted compounds that selectively bind cardiolipin to support bioenergetic efficiency and membrane integrity. Below, we review its molecular architecture, mechanisms of action, published experimental model systems, and critical analytical purity requirements.
Quick answer
This SS-31 research guide provides principal investigators and laboratory specialists with a detailed analysis of the Szeto-Schiller-31 (Elamipretide) tetrapeptide. Synthesized for rigorous in vitro and preclinical research, SS-31 represents a unique class of mitochondria-targeted compounds that selectively bind cardiolipin to support bioenergetic efficiency and membrane integrity. Below, we review its molecular architecture, mechanisms of action, published experimental model systems, and critical analytical purity requirements.
Key takeaways
- [SS-31](/research-peptides/ss-31), also known in scientific literature as Elamipretide or Bendavia, is a small, cell-permeable synthetic tetrapeptide belonging to the Szeto-Schiller (SS) peptide family.
- The primary structure of [SS-31](/research-peptides/ss-31) is defined by the amino acid sequence D-Arg-2',6'-Dmt-Lys-Phe-NH2, incorporating the non-canonical amino acid 2',6'-dimethyltyrosine (Dmt).
- The defining mechanistic feature of [SS-31](/research-peptides/ss-31) is its high-affinity, selective binding to cardiolipin—a unique tetra-acyl phospholipid localized almost exclusively within the inner mitochondrial membrane.
- In vitro assays evaluating mitochondrial bioenergetics demonstrate that [SS-31](/research-peptides/ss-31) treatment restores maximal respiration capacity and coupling efficiency in damaged or stressed mitochondria.
Introduction to SS-31 (Elamipretide) in Preclinical Research
SS-31, also known in scientific literature as Elamipretide or Bendavia, is a small, cell-permeable synthetic tetrapeptide belonging to the Szeto-Schiller (SS) peptide family. Discovered during investigations into cell-permeable aromatic-cationic peptide sequences, SS-31 was specifically designed to target the inner mitochondrial membrane (IMM) without relying on the mitochondrial membrane potential. This structural distinction separates it from conventional lipophilic cations, making it a pivotal tool within the broader category of mitochondrial-targeted peptides.
In cell culture and animal model systems, SS-31 is routinely utilized to investigate pathways associated with mitochondrial dysfunction, oxidative stress, and ATP production attenuation. Because mitochondrial structural integrity is vital across various physiological systems, researchers employ SS-31 across diverse disciplines—including nephrology, cardiology, and neurobiology. All data detailed within this guide pertain strictly to controlled laboratory environments and non-human model systems.
Molecular Structure and Physicochemical Profile
The primary structure of SS-31 is defined by the amino acid sequence D-Arg-2',6'-Dmt-Lys-Phe-NH2, incorporating the non-canonical amino acid 2',6'-dimethyltyrosine (Dmt). The inclusion of alternating basic residues (Arginine and Lysine) and aromatic residues (Dmt and Phenylalanine) endows the molecule with a balanced structural motifs featuring both positive charges and lipophilicity. This sequence allows SS-31 to cross eukaryotic cellular membranes rapidly via passive diffusion.
Crucially, the presence of D-arginine at the N-terminus renders the peptide highly resistant to ubiquitous intracellular peptidases and proteases, substantially enhancing its stability in cell culture media and ex vivo tissue assays. Upon cellular entry, the cationic nature of SS-31 drives its concentration-dependent localization to the negatively charged inner mitochondrial membrane, where it interacts directly with specialized membrane lipids.
Primary Mechanism of Action: Cardiolipin Interaction
The defining mechanistic feature of SS-31 is its high-affinity, selective binding to cardiolipin—a unique tetra-acyl phospholipid localized almost exclusively within the inner mitochondrial membrane. Cardiolipin plays a fundamental role in maintaining cristae architecture, stabilizing electron transport chain (ETC) supercomplexes (respirasomes), and regulating mitochondrial permeability transition pore (mPTP) dynamics.
Preclinical studies suggest that under conditions of oxidative stress, cardiolipin undergoes peroxidation, which disrupts its interaction with Cytochrome c and destabilizes electron transport complexes. Electrostatic and hydrophobic interactions allow SS-31 to insert into the cardiolipin headgroup interface. By forming an SS-31–cardiolipin complex, the peptide inhibits cardiolipin peroxidation, stabilizes the curvature of the inner membrane, and prevents the dissociation of Cytochrome c, thereby preserving electron transfer kinetics along the respiratory chain.
Mitochondrial Bioenergetics and ROS Mitigation
In vitro assays evaluating mitochondrial bioenergetics demonstrate that SS-31 treatment restores maximal respiration capacity and coupling efficiency in damaged or stressed mitochondria. By optimizing the structural alignment of ETC Complexes I, III, and IV within supercomplexes, SS-31 reduces electron leak—the primary source of intracellular superoxide anion (O2•-) production.
Unlike generic non-targeted antioxidant molecules that scavenge reactive oxygen species (ROS) indiscriminately throughout the cytosol, SS-31 functions at the site of electron generation. In vitro data indicate that this targeted mechanism decreases mitochondrial ROS production while simultaneously preserving the proton motive force required for ATP synthase (Complex V) activity. Consequently, researchers frequently utilize the SS-31 50mg vial as a benchmark control when evaluating bioenergetic restoration in cellular stress models.
Preclinical Applications in Organ Ischemia-Reperfusion Models
A substantial portion of published literature regarding SS-31 focuses on animal models of ischemia-reperfusion (IR) injury. Ischemia causes rapid depletion of cellular ATP, loss of mitochondrial membrane potential, and accumulation of intracellular calcium. Upon reperfusion, a massive surge of ROS triggers the opening of the mPTP, leading to mitochondrial swelling, membrane rupture, and apoptotic signaling cascades.
Rodent models of acute kidney injury (AKI) and myocardial infarction demonstrate that administration of SS-31 prior to or during reperfusion preserves cristae microarchitecture, attenuates mPTP opening, and reduces necrotic core expansion. Furthermore, in ex vivo organ preservation studies, incubation with SS-31 has been shown to reduce cold ischemia-induced endothelial damage, highlighting its utility in transplantation and tissue preservation research.
Neurodegenerative and Metabolic Research Paradigms
Beyond acute ischemic models, SS-31 is widely investigated in chronic disease models characterized by mitochondrial decay. In transgenic mouse models of neurodegenerative pathologies (such as Amyotrophic Lateral Sclerosis and Alzheimer's disease), research indicates that SS-31 decreases neuroinflammatory signaling, reduces amyloid-beta-induced mitochondrial fragmentation, and supports synaptic plasticity.
In metabolic research, animal models exposed to high-fat diets or age-associated metabolic decline exhibit improved insulin sensitivity and reduced skeletal muscle atrophy following SS-31 intervention. Researchers measure parameters such as mitochondrial oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and citrate synthase activity to map the long-term metabolic adaptations induced by the peptide.
Comparative Analysis: SS-31 vs. Other Mitochondrial Modulators
When designing mitochondrial research assays, investigators frequently evaluate SS-31 alongside other mitochondria-targeted candidates to compare distinct pathways of action. For instance, mots-c research centers on a mitochondrially derived peptide that acts as an AMPK activator regulating nuclear gene expression and systemic metabolic homeostasis, whereas SS-31 acts locally on membrane lipid architecture.
Similarly, the humanin peptide operates primarily through cytoprotective signaling pathways and interaction with cell-surface or cytosolic receptors to prevent apoptosis. In contrast, small-molecule mitochondrial antioxidants like MitoQ rely on a lipophilic triphenylphosphonium (TPP+) cation that depends strictly on a high mitochondrial membrane potential for accumulation. SS-31 remains unique because its binding to cardiolipin is charge- and lipid-dependent rather than potential-dependent, maintaining efficacy even in severely depolarized mitochondria. Accessing the full PX1 Research Catalog allows laboratories to cross-compare these distinct mechanistical classes in parallel studies.
Reconstitution, Storage, and Handling Guidelines for Laboratory Use
To preserve chemical stability and ensure reproducible experimental outcomes, rigorous handling protocols must be observed. Lyophilized SS-31 should be stored at -20°C or -80°C in a desiccated environment away from light. Upon receipt, vials should be allowed to equilibrate to room temperature before reconstitution to prevent atmospheric moisture condensation inside the container.
For aqueous in vitro experiments, SS-31 solubilizes readily in sterile phosphate-buffered saline (PBS, pH 7.4) or high-grade molecular biology water. When long-term stock solution storage is required for repeated cell culture dosing, reconstituting with sterile bacteriostatic water can prevent microbial growth. Aliquots of reconstituted peptide should be stored at -80°C to minimize freeze-thaw degradation cycles.
Purity Verification, Mass Spectrometry, and Endotoxin Control
Preclinical data integrity relies entirely on the purity and analytical verification of the research peptides employed. Impurities such as truncated peptide sequences, organic solvents, or heavy metals can confound bioenergetic assays, alter cell viability readings, or induce non-specific cytotoxic responses.
PX1 Research enforces strict quality control standards for every lot of SS-31 synthesized. Analytical testing via High-Performance Liquid Chromatography (HPLC) verifies target purity levels exceeding 98%. Liquid Chromatography-Mass Spectrometry (LC-MS) is utilized to confirm exact molecular weight and sequence identity. Additionally, because bacterial lipopolysaccharides (endotoxins) stimulate innate immune signaling in primary cell cultures and rodent models, all lots undergo quantitative chromogenic LAL testing to guarantee endotoxin levels fall strictly below standard research limits (<0.01 EU/mg).
Procurement and Institutional Lab Support
Acquiring reliable, highly characterized compounds is a critical step in maintaining experimental repeatability across study cohorts. PX1 Research serves academic institutions, contract research organizations (CROs), and private biotechnology facilities with transparent analytical documentation accompanying every shipment.
All products are USA-synthesized and validated by independent ISO 17025 accredited laboratories. Vials are dispatched rapidly from centralized distribution facilities in California and Arizona, offering same-day dispatch for orders confirmed Monday through Friday. Laboratories scaling up high-throughput screens or multi-animal studies can utilize our dedicated wholesale peptide program to obtain bulk lot reservation and batch-specific Certificate of Analysis (COA) documentation.
Frequently Asked Questions
What is the primary target of SS-31 within the cell?
SS-31 selectively targets cardiolipin, an essential phospholipid localized exclusively in the inner mitochondrial membrane, where it stabilizes membrane structure and electron transport chain complexes.
How does SS-31 differ from MitoQ or conventional antioxidants?
Unlike MitoQ, which relies on a voltage-dependent triphenylphosphonium cation to cross membranes, SS-31 targets cardiolipin directly via electrostatic interactions without requiring a intact mitochondrial membrane potential.
What purity standard is recommended for SS-31 in cell culture assays?
In vitro bioenergetic and cell culture studies require a minimum HPLC purity of >98% alongside verified low endotoxin levels to prevent non-specific inflammatory responses or cell toxicity.
How should lyophilized SS-31 be stored upon arrival?
Lyophilized SS-31 should be stored in a freezer at -20°C or -80°C, protected from light and moisture, to ensure long-term chemical stability.
What diluent should be used to reconstitute SS-31 for in vitro assays?
For immediate cellular assays, sterile phosphate-buffered saline (PBS) or sterile water for injection is standard. For multi-use stock solutions stored at 4°C for short periods, bacteriostatic water may be used.
Why is endotoxin testing critical for SS-31 research?
Endotoxins (LPS) can trigger TLR4 signaling pathways in immune and parenchymal cell models, creating false-positive or confounding inflammatory data in mitochondrial stress assays.
Is SS-31 suitable for human consumption or clinical administration?
No. SS-31 supplied by PX1 Research is strictly a research-grade chemical intended exclusively for laboratory, in vitro, and non-human animal research.
What analytical documentation is provided with PX1 Research SS-31?
Every lot of SS-31 includes a lot-specific Certificate of Analysis (COA) detailing HPLC purity profiles, LC-MS mass spectrum verification, and quantitative endotoxin test results.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.